Market Overview

UPDATE: Bank of America Merrill Lynch Reiterates Neutral Rating, Raises PT on CR Bard

Share:
Related BCR
Benzinga's Top Upgrades
Goldman Remains Constructive on MedTech, Sees 'New Opportunities' Amid Selloff
Henry Schein Poised on Acquisitions, Strong Fundamentals (Zacks)

In a report published Monday, Bank of America Merrill Lynch reiterated its Neutral rating on CR Bard (NYSE: BCR), and raised its price target from $103.00 to $113.00.

BofA Merrill Lynch noted, “BCR's model has succeeded in driving a 10%+ revenue CAGR for the last four years, but for the last several quarters, growth has slowed to the 6% range, as the combination of the economy and new competitive dynamics has affected BCR's growth. In BCR's latest three quarters that growth slowed to the 3% range. We have considerable confidence in the BCR management team but given the uncertainty around growth and BCR's premium to the group we see limited upside to the current stock price.”

CR Bard closed on Friday at $102.33.

Latest Ratings for BCR

DateFirmActionFromTo
Aug 2015Goldman SachsUpgradesNeutralBuy
Aug 2015KeyBancInitiates Coverage onSector Weight
Apr 2015Bank of AmericaUpgradesUnderperformBuy

View More Analyst Ratings for BCR
View the Latest Analyst Ratings

Posted-In: Bank of America Merrill LynchAnalyst Color Price Target Analyst Ratings

 

Related Articles (BCR)

View Comments and Join the Discussion!

Get Benzinga's Newsletters